Office of Science and Health Coordination

The Office of Science and Health Coordination advises the FDA commissioner and senior managers on Agency science issues, develops/implements/coordinates science and public health initiatives Agency-wide, and serves as focus for designated Agency cross-cutting external science issues. OSHC includes the immediate office of the Director, the Good Clinical Practice Program, the Office of Orphan Product Development, and the Office of Women's Health.